Société Loxo Oncology Inc
Actions
US5488621013
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 39 | 01/05/14 | |
President | - | - | |
Anthony Sireci
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Liz Beja
COO | Chief Operating Officer | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Compliance Officer | - | 01/04/18 | |
Human Resources Officer | - | - | |
Amy Rose
HRO | Human Resources Officer | - | 01/01/20 |
Philip Johnson
LAW | General Counsel | - | 01/11/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 30 614 536 | 29 481 314 ( 96,30 %) | 0 | 96,30 % |
Coordonnées société
Loxo Oncology, Inc.
281 Tresser Boulevard 9th floor
06901, Stamford
+203-653-3880
http://www.loxooncology.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+10,79 % | 115 Md | |
+11,65 % | 106 Md | |
-6,20 % | 24,69 Md | |
-2,33 % | 21,97 Md | |
-6,03 % | 19,27 Md | |
-13,41 % | 17,56 Md | |
-40,50 % | 17,32 Md | |
+6,64 % | 14,03 Md | |
+31,84 % | 12,13 Md |